檢索結果 - Muhammad K Javaid
- Showing 1 - 9 results of 9
-
1
-
2
Protocol of a randomised trial of teriparatide followed by zoledronic acid to reduce fracture risk in adults with osteogenesis imperfecta 由 Jennifer Walsh, Catriona Keerie, Stuart H Ralston, Christopher J Weir, Muhammad K Javaid, WAYNE LAM, Bente L Langdahl, Jannie D Hald, Patricia Osborne
發表在 BMJ Open (2023-11-01)獲取全文
Article -
3
Patients’ recovery of mobility and return to original residence after hip fracture are associated with multiple modifiable components of hospital service organisation: the REDUCE r... 由 Rita Patel, Andrew Judge, Antony Johansen, Elsa M. R. Marques, Tim Chesser, Xavier L. Griffin, Muhammad K. Javaid, REDUCE Study Group, Yoav Ben-Shlomo, Celia L. Gregson
發表在 BMC Geriatrics (2023-07-01)獲取全文
Article -
4
Exercise or manual physiotherapy compared with a single session of physiotherapy for osteoporotic vertebral fracture: three-arm PROVE RCT 由 Karen L Barker, Meredith Newman, Nigel Stallard, Jose Leal, Catherine Minns Lowe, Muhammad K Javaid, Angela Noufaily, Anish Adhikari, Tamsin Hughes, David J Smith, Varsha Gandhi, Cyrus Cooper, Sarah E Lamb
發表在 Health Technology Assessment (2019-08-01)獲取全文
Article -
5
Assessing a 12-month course of oral alendronate for adults with avascular necrosis of the hip: MANTIS RCT with internal pilot 由 Sion Glyn-Jones, Muhammad K Javaid, David Beard, Julia Newton, Robert Kerslake, Callum McBryde, Tim Board, Susan J Dutton, Melina Dritsaki, Vikas Khanduja, Magbor Akanni, Shaun Sexton, John Skinner, Nicholas Peckham, Ruth Knight, Ines Rombach, Loretta Davies, Vicki Barber
發表在 Health Technology Assessment (2022-10-01)獲取全文
Article -
6
REducing unwarranted variation in the Delivery of high qUality hip fraCture services in England and Wales (REDUCE): protocol for a mixed-methods study 由 Rita Patel, Elsa M R Marques, Yoav Ben-Shlomo, Andrew Judge, Sarah Drew, Rachael Gooberman-Hill, Xavier L Griffin, Tim Jones, Katie Whale, Antony Johansen, Estela Capelas Barbosa, Tim Chesser, Muhammad K Javaid, Celia L Gregson, Jill Griffin, Marianne Bradshaw
發表在 BMJ Open (2021-05-01)獲取全文
Article -
7
Benefit of burosumab in adults with X-linked hypophosphataemia (XLH) is maintained with long-term treatment 由 Karine Briot, Wei Sun, Rachel K Crowley, Maria Luisa Brandi, Stuart H Ralston, Peter Kamenický, Martine Cohen-Solal, Richard Keen, Angela Williams, Muhammad K Javaid, Robin H Lachmann, Annabel Nixon, Mark Nixon, Anne-Lise Lecoq, Sami Kolta, Jennifer S Walsh, Angela J Rylands
發表在 RMD Open (2023-02-01)獲取全文
Article -
8
Longitudinal dynamics and clinically available predictors of poor response to COVID-19 vaccination in multiple myeloma 由 Gaurav Agarwal, Sally Moore, Ross Sadler, Sherin Varghese, Alison Turner, Lucia Y Chen, Jemma Larham, Nathanael Gray, Oluremi Carty, Joe Barrett, Constantinos Koshiaris, Jaimal Kothari, Stella Bowcock, Udo Oppermann, Vicky Gamble, Gordon Cook, Chara Kyriakou, Mark Drayson, Supratik Basu, Sarah McDonald, Shelagh McKinley, Sarah Gooding, Muhammad K Javaid, Karthik Ramasamy
發表在 Haematologica (2024-01-01)獲取全文
Article -
9
Burosumab treatment in adults with X-linked hypophosphataemia: 96-week patient-reported outcomes and ambulatory function from a randomised phase 3 trial and open-label extension 由 Karine Briot, Rachel K Crowley, Maria Luisa Brandi, Stuart H Ralston, Han-Wook Yoo, Peter Kamenický, Takuo Kubota, Nobuaki Ito, Martine Cohen-Solal, Richard Keen, Angela Williams, Muhammad K Javaid, Hiroyuki Tanaka, Robin H Lachmann, Karl Insogna, Richard Eastell, Yasuhiro Takeuchi, Anthony A Portale, Thomas O Carpenter, Hae Ii Cheong, Yasuo Imanishi, Steven Ing, Suzanne Jan de Beur, Farzana Perwad, Pisit Pitukcheewanont, Thomas J Weber, Annabel Nixon, Mark Nixon, Erik A Imel
發表在 RMD Open (2021-11-01)獲取全文
Article
